EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2019 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • Massachusetts
This Employment Agreement (the "Agreement") is made and entered into effective as of this 8th day of April 2019 (the "Effective Date") by and between Oxford lmmunotec USA, Inc., a Delaware corporation with a usual place of business at 700 Nickerson Road, Suite 200, Marlborough, MA 01752 (the "Company") and Matthew McLaughlin (the "Employee").
THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED SIXTH AMENDMENT TO...Distributorship Agreement • August 6th, 2019 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
THIS SIXTH AMENDMENT to Distributorship Agreement (“Amendment”) is made this __ day of June, 2019 by and between Oxford Immunotec Limited, a company incorporated in England with number 04516079, whose registered office is at 94C Innovation Drive, Milton Park, Abingdon, Oxfordshire OX154 4RZ (the “Company”) and Fosun Long March Medical Science Co. Ltd., (registration number Shanghai Joint-Venture 000422) whose registered office and principal place of business is both at 830 Cheng Yin Road, Shanghai, China 200444 (“Fosun Shanghai I”) and Shanghai Xin Chang Medical Device Co. Ltd (registration number 310110000477786), whose registered office and principal place of business is at number 830 Cheng Yin Road, Shanghai, China 200444 (“Fosun Shanghai II”) Fosun Shanghai I and Fosun Shanghai II are herein collectively referred to as “Distributors”.
